Business Context and Reporting Period
This Form 6-K filing by Brookfield Business Partners L.P. (BBU) is dated September 26, 2023. The filing serves to provide recast audited consolidated financial statements and a recast Management's Discussion and Analysis (MD&A) for the year ended December 31, 2022. These updates are necessary due to the mandatory adoption of IFRS 17 (Insurance contracts) for annual periods beginning on or after January 1, 2023.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Instead, it references the attached exhibits (99.1 and 99.2) which contain the recast financial data. The filing explicitly states that the recast statements supersede the financial information previously presented in the Annual Report on Form 20-F filed on March 7, 2023.
Material Changes Versus Prior Period
The primary material change disclosed is the restatement of financial results for the years ended December 31, 2022, and December 31, 2021, to conform with IFRS 17. The filing notes that no other information in the original Form 20-F has been modified or updated, and disclosures not affected by the IFRS 17 adoption remain unchanged.
Guidance, Outlook, and Risks
This filing does not contain new guidance, outlook, or management commentary beyond the restatement of historical data. The document clarifies that it should be read in conjunction with the original Form 20-F, as the only updates pertain to the accounting standard change. No new risks or contingencies are introduced in this specific report.
Investor Verification Checklist
- Verify the specific impact of IFRS 17 adoption on insurance contract recognition and measurement by reviewing Exhibit 99.1 (Recast Audited Consolidated Financial Statements).
- Compare the recast MD&A in Exhibit 99.2 against the original Form 20-F to understand changes in operating and financial review.
- Confirm that all other disclosures in the March 7, 2023 Form 20-F remain valid and unchanged as stated in this filing.
- Review the consent of Deloitte LLP (Exhibit 99.5) regarding the recast financial statements.